Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production

  • US 6,897,294 B2
  • Filed: 03/20/2002
  • Issued: 05/24/2005
  • Est. Priority Date: 05/07/1996
  • Status: Expired due to Fees
First Claim
Patent Images

1. A chimeric VEGF receptor protein comprising immunoglobulin (Ig)-like domains from two or more different VEGF receptor molecules, wherein said chimeric VEGF receptor protein comprises Ig-like domain 2 of flt-1 receptor or Ig-like domain 2 of KDR receptor.

View all claims

    Thank you for your feedback